Most Patient-Reported Outcome Measures in CVD Fall Short

Most Patient-Reported Outcome Measures in CVD Fall Short

Only a minority of the instruments used in clinical and research settings to evaluate patient-reported outcome measures (PROMs) in CVD care adhere to quality standards set by the US Food and Drug Administration or to consensus-based metrics, according to a review of 50 such tools. Health status PROMs that assess symptom burden, functional status, and health-related quality of life give the patient a voice in their care, provide tools for measuring treatment effects in research, and in some cases have …